Peter Nygren Selected Research

Peter Nygren Research Topics

Disease

65	Neoplasms (Cancer) 01/2022 - 01/2002
19	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2003
9	Colonic Neoplasms (Colon Cancer) 04/2022 - 12/2011
8	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 08/2007
7	Peritoneal Neoplasms 01/2018 - 06/2011
7	Carcinoma (Carcinomatosis) 12/2017 - 06/2006
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2011 - 01/2004
4	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 11/2014
4	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2011
4	Leukemia 08/2013 - 12/2003
4	Lymphoma (Lymphomas) 01/2003 - 04/2002
3	Nausea 01/2019 - 06/2005
3	Pseudomyxoma Peritonei 12/2015 - 04/2012
3	Hypoxia (Hypoxemia) 06/2015 - 07/2011
3	Stomach Neoplasms (Stomach Cancer) 12/2014 - 01/2012
3	Breast Neoplasms (Breast Cancer) 06/2008 - 07/2005
2	Fatigue 05/2021 - 01/2019
2	Vomiting 01/2019 - 06/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2017 - 08/2007
2	Thrombocytopenia (Thrombopenia) 12/2015 - 05/2010
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2010 - 02/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2008 - 10/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2007 - 01/2007
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Chronic Disease (Chronic Diseases) 05/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2019
1	Anemia 01/2019
1	Constipation 01/2019
1	Multiple Myeloma 09/2017
1	Infections 08/2017

Drug/Important Bio-Agent (IBA)

43	Pharmaceutical PreparationsIBA 08/2021 - 01/2002
7	Fluorouracil (Carac)FDA LinkGeneric 08/2021 - 07/2005
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2019 - 09/2013
5	Melphalan (Alkeran)FDA LinkGeneric 09/2017 - 12/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2015 - 10/2004
5	Docetaxel (Taxotere)FDA Link 12/2014 - 06/2005
5	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 05/2010 - 04/2002
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2012
4	IronIBA 09/2019 - 07/2011
4	VLX600IBA 09/2019 - 01/2014
4	Mebendazole (Anti-Worm)FDA Link 07/2018 - 12/2013
4	Irinotecan (Camptosar)FDA LinkGeneric 12/2015 - 03/2010
4	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 03/2012
3	nitazoxanide (NTZ)FDA Link 04/2022 - 06/2015
3	EnzymesIBA 11/2020 - 04/2002
3	Biomarkers (Surrogate Marker)IBA 07/2018 - 08/2016
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 12/2008
3	melflufenIBA 09/2017 - 12/2015
3	Alkylating AgentsIBA 09/2016 - 06/2008
3	Peptide Hydrolases (Proteases)FDA Link 09/2016 - 07/2003
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2015 - 09/2013
3	AnthelminticsIBA 06/2015 - 12/2013
3	Bortezomib (Velcade)FDA Link 12/2014 - 01/2009
3	dicyandiamido (cyanoguanidine)IBA 01/2004 - 04/2002
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 12/2014
2	Phosphotransferases (Kinase)IBA 11/2020 - 01/2018
2	Chelating AgentsIBA 01/2019 - 12/2016
2	Drug CombinationsIBA 11/2017 - 12/2008
2	AminopeptidasesIBA 09/2017 - 12/2015
2	CD13 Antigens (Alanine Aminopeptidase)IBA 09/2017 - 03/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2017 - 02/2013
2	UbiquitinIBA 05/2017 - 02/2013
2	Antineoplastic Agents (Antineoplastics)IBA 05/2017 - 08/2015
2	CD 02750IBA 05/2017 - 07/2011
2	PlatinumIBA 09/2016 - 12/2015
2	ErbB Receptors (EGF Receptor)IBA 08/2016 - 01/2012
2	Imatinib Mesylate (Gleevec)FDA Link 08/2015 - 03/2012
2	Fluorescein (Funduscein)FDA LinkGeneric 12/2014 - 08/2012
2	Quillaja SaponinsIBA 01/2013 - 02/2010
2	Tumor Biomarkers (Tumor Markers)IBA 12/2012 - 09/2012
2	Etoposide (VP 16)FDA LinkGeneric 06/2008 - 10/2004
2	Epirubicin (Ellence)FDA LinkGeneric 01/2007 - 07/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007 - 07/2005
2	Disulfiram (Antabuse)FDA Link 01/2007 - 03/2006
1	Green Fluorescent ProteinsIBA 04/2022
1	regorafenibIBA 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2020
1	NucleotidesIBA 11/2020
1	Oxygen (Dioxygen)IBA 09/2019
1	Hormones (Hormone)IBA 09/2019
1	Alkaline PhosphataseIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2018
1	Biocompatible Materials (Biomaterials)IBA 02/2018
1	Hydroxyindoleacetic AcidIBA 01/2018
1	Chromogranin AIBA 01/2018
1	Protein Kinase InhibitorsIBA 01/2018
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 12/2017
1	Antimalarials (Antimalarial Agents)IBA 12/2017
1	Quinacrine (Mepacrine)IBA 12/2017
1	CopperIBA 05/2017
1	ThiosemicarbazonesIBA 05/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2016
1	Mevalonic Acid (Mevalonate)IBA 11/2016
1	Gemcitabine FDA Link 09/2016
1	liposomal doxorubicin (Doxil)FDA Link 09/2016

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 11/2020 - 01/2002
11	Therapeutics 05/2021 - 01/2007
9	Cytoreduction Surgical Procedures 09/2016 - 06/2011
5	Hyperthermic Intraperitoneal Chemotherapy 08/2015 - 06/2011
3	Radiotherapy 07/2020 - 11/2014